OWC Pharmaceutical Research Corp. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced net loss was USD 287,000 compared to USD 992,000 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago. For the nine months, net income was USD 6.420 million compared to net loss of USD 5.178 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to basic loss per share from continuing operations of USD 0.04 a year ago. Diluted earnings per share from continuing operations was USD 0.02 compared to diluted loss per share from continuing operations of USD 0.05 a year ago.